Global Information
회사소개 | 문의

뇌척수액 관리 장비 : 의료기기 파이프라인 평가

Cerebro Spinal Fluid (CSF) Management - Medical Devices Pipeline Assessment, 2018

리서치사 GlobalData
발행일 2018년 06월 상품 코드 383659
페이지 정보 영문 102 Pages
가격
US $ 4,000 ₩ 4,515,200 PDF by E-mail (Single user license) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 8,000 ₩ 9,030,400 PDF by E-mail (Site license) help
동일 사업장 내 모든 분들이 공유하여 사용할 수 있습니다. 이용 인원수에 제한은 없습니다. PDF 파일은 Copy & Paste가 가능합니다. PDF 내의 컨텐츠 인쇄는 제한이 없으나, 전체보고서에 대한 제본은 원칙적으로 2부까지만 허용되며, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 12,000 ₩ 13,545,600 PDF by E-mail (Global license) help
동일 기업의 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없으며, 해외 사업장 및 100% 자회사는 동일 기업으로 간주됩니다. PDF 파일은 Copy & Paste가 가능합니다. PDF 내의 컨텐츠 인쇄는 제한이 없으나, 전체보고서에 대한 제본은 원칙적으로 10부까지만 허용되며, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.


뇌척수액 관리 장비 : 의료기기 파이프라인 평가 Cerebro Spinal Fluid (CSF) Management - Medical Devices Pipeline Assessment, 2018
발행일: 2018년 06월 페이지 정보 : 영문 102 Pages

이 페이지에 게재되어 있는 내용은 최신판과 약간 차이가 있을 수 있으므로 영문목차를 함께 참조하여 주시기 바랍니다. 기타 자세한 사항은 문의 바랍니다.

한글목차

뇌척수액 관리 장비의 파이프라인 제품에 대해 조사분석했으며, 개발 단계별 비교 분석, 파이프라인 제품의 개발에 참여하고 있는 주요 기업, 진행중인 임상시험에 관한 정보 등을 정리하여 전해드립니다.

제1장 목차

제2장 서론

  • 뇌척수액 관리 장비 개요

제3장 개발중인 제품

  • 뇌척수액 관리 장비 - 파이프라인 제품 : 개발 단계별
  • 뇌척수액 관리 장비 - 파이프라인 제품 : 부문별
  • 뇌척수액 관리 장비 - 파이프라인 제품 : 지역별
  • 뇌척수액 관리 장비 - 파이프라인 제품 : 규제별
  • 뇌척수액 관리 장비 - 파이프라인 제품 : 승인 예정일별
  • 뇌척수액 관리 장비 - 진행중인 임상시험

제4장 뇌척수액 관리 장비 - 개발중인 파이프라인 제품 : 기업별

  • 뇌척수액 관리 장비 기업 - 파이프라인 제품 : 개발 단계별
  • 뇌척수액 관리 장비 - 파이프라인 제품 : 개발 단계별

제5장 뇌척수액 관리 장비 기업과 제품 개요

  • Alcyone Lifesciences, Inc.
  • Aqueduct Neurosciences
  • Arkis BioSciences
  • Beckersmith Medical, Inc.
  • Biosan Medical Ltd.
  • Georgia Institute of Technology
  • H-Cubed Inc.
  • Integra LifeSciences Holdings Corporation
  • InVivo Therapeutics Corporation
  • Kerecis ehf
  • Microbot Medical, Ltd.
  • Nanonerve Inc.
  • NeuraMedica, LLC
  • NexGen Medical Systems, Inc.
  • Sree Chitra Tirunal Institute for Medical Sciences & Technology
  • System Science Inc.
  • University Hospital Zurich
  • University of Rochester
  • University of South Florida
  • University of Wisconsin Madison
  • Vivonics, Inc.
  • Wayne State University

제6장 뇌척수액 관리 장비 - 최근 동향

제7장 부록

도표

KSA 16.11.14

영문목차

GlobalData's Medical Devices sector report, "Cerebro Spinal Fluid (CSF) Management - Medical Devices Pipeline Assessment, 2018" provides an overview of Cerebro Spinal Fluid (CSF) Management currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Cerebro Spinal Fluid (CSF) Management pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Cerebro Spinal Fluid (CSF) Management under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Cerebro Spinal Fluid (CSF) Management and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry.

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Cerebro Spinal Fluid (CSF) Management under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date.

Table of Contents

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 5
  • 1.2 List of Figures 7

2 Introduction 8

  • 2.1 Cerebro Spinal Fluid (CSF) Management Overview 8

3 Products under Development 9

  • 3.1 Cerebro Spinal Fluid (CSF) Management - Pipeline Products by Stage of Development 9
  • 3.2 Cerebro Spinal Fluid (CSF) Management - Pipeline Products by Segment 10
  • 3.3 Cerebro Spinal Fluid (CSF) Management - Pipeline Products by Territory 11
  • 3.4 Cerebro Spinal Fluid (CSF) Management - Pipeline Products by Regulatory Path 12
  • 3.5 Cerebro Spinal Fluid (CSF) Management - Pipeline Products by Estimated Approval Date 13
  • 3.6 Cerebro Spinal Fluid (CSF) Management - Ongoing Clinical Trials 14

4 Cerebro Spinal Fluid (CSF) Management - Pipeline Products under Development by Companies 15

  • 4.1 Cerebro Spinal Fluid (CSF) Management Companies - Pipeline Products by Stage of Development 15
  • 4.2 Cerebro Spinal Fluid (CSF) Management - Pipeline Products by Stage of Development 17

5 Cerebro Spinal Fluid (CSF) Management Companies and Product Overview 19

  • 5.1 Alcyone Lifesciences Inc Company Overview 19
    • 5.1.1 Alcyone Lifesciences Inc Pipeline Products & Ongoing Clinical Trials Overview 19
  • 5.2 Arkis BioSciences Company Overview 20
    • 5.2.1 Arkis BioSciences Pipeline Products & Ongoing Clinical Trials Overview 20
  • 5.3 Beckersmith Medical, Inc. Company Overview 21
    • 5.3.1 Beckersmith Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 21
  • 5.4 Biosan Medical Ltd. Company Overview 22
    • 5.4.1 Biosan Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 22
  • 5.5 CereVasc LLC Company Overview 23
    • 5.5.1 CereVasc LLC Pipeline Products & Ongoing Clinical Trials Overview 23
  • 5.6 Collagen Matrix Inc Company Overview 24
    • 5.6.1 Collagen Matrix Inc Pipeline Products & Ongoing Clinical Trials Overview 24
  • 5.7 Georgia Institute of Technology Company Overview 25
    • 5.7.1 Georgia Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 25
  • 5.8 H-Cubed Inc. Company Overview 26
    • 5.8.1 H-Cubed Inc. Pipeline Products & Ongoing Clinical Trials Overview 26
  • 5.9 Integra LifeSciences Holdings Corp Company Overview 27
    • 5.9.1 Integra LifeSciences Holdings Corp Pipeline Products & Ongoing Clinical Trials Overview 27
  • 5.10 InVivo Therapeutics Corp Company Overview 31
    • 5.10.1 InVivo Therapeutics Corp Pipeline Products & Ongoing Clinical Trials Overview 31
  • 5.11 Johns Hopkins University Company Overview 32
    • 5.11.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 32
  • 5.12 Kerecis ehf Company Overview 33
    • 5.12.1 Kerecis ehf Pipeline Products & Ongoing Clinical Trials Overview 33
  • 5.13 Kuros Biosciences AG Company Overview 34
    • 5.13.1 Kuros Biosciences AG Pipeline Products & Ongoing Clinical Trials Overview 34
  • 5.14 Leucadia Therapeutics Company Overview 36
    • 5.14.1 Leucadia Therapeutics Pipeline Products & Ongoing Clinical Trials Overview 36
  • 5.15 Microbot Medical Ltd Company Overview 37
    • 5.15.1 Microbot Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 37
  • 5.16 Monitor Med Solutions Company Overview 40
    • 5.16.1 Monitor Med Solutions Pipeline Products & Ongoing Clinical Trials Overview 40
  • 5.17 Nanonerve Inc. Company Overview 41
    • 5.17.1 Nanonerve Inc. Pipeline Products & Ongoing Clinical Trials Overview 41
  • 5.18 NeuraMedica, LLC Company Overview 42
    • 5.18.1 NeuraMedica, LLC Pipeline Products & Ongoing Clinical Trials Overview 42
  • 5.19 NexGen Medical Systems Inc Company Overview 43
    • 5.19.1 NexGen Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 43
  • 5.20 Nurami Medical Ltd Company Overview 44
    • 5.20.1 Nurami Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 44
  • 5.21 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview 45
    • 5.21.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 45
  • 5.22 System Science Inc. Company Overview 47
    • 5.22.1 System Science Inc. Pipeline Products & Ongoing Clinical Trials Overview 47
  • 5.23 University Hospital Zurich Company Overview 49
    • 5.23.1 University Hospital Zurich Pipeline Products & Ongoing Clinical Trials Overview 49
  • 5.24 University of Iowa Company Overview 50
    • 5.24.1 University of Iowa Pipeline Products & Ongoing Clinical Trials Overview 50
  • 5.25 University of Rochester Company Overview 51
    • 5.25.1 University of Rochester Pipeline Products & Ongoing Clinical Trials Overview 51
  • 5.26 University of South Florida Company Overview 52
    • 5.26.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 52
  • 5.27 University of Wisconsin Madison Company Overview 54
    • 5.27.1 University of Wisconsin Madison Pipeline Products & Ongoing Clinical Trials Overview 54
  • 5.28 Vivonics, Inc. Company Overview 56
    • 5.28.1 Vivonics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 56
  • 5.29 Wayne State University Company Overview 57
    • 5.29.1 Wayne State University Pipeline Products & Ongoing Clinical Trials Overview 57

6 Cerebro Spinal Fluid (CSF) Management- Recent Developments 58

  • 6.1 May 09, 2018: Microbot Medical Announces Receiving Notice of Allowance for a U.S. Patent covering its Self-Cleaning Shunt (SCS) Device 58
  • 6.2 May 07, 2018: Medtronic Appoints Mike Weinstein As Senior Vice President Of Strategy 58
  • 6.3 May 07, 2018: Integra LifeSciences Announces Amendment and Extension of Credit Facility 59
  • 6.4 Apr 25, 2018: LeMaitre Q1 2018 Sales $26.0mm (+8%), EPS $0.19 (+17%) 59
  • 6.5 Apr 24, 2018: Arkis BioSciences Brings Endexo Technology To Neurosurgical Use With Its New CerebroFlo EVD Catheter 60
  • 6.6 Apr 20, 2018: Cook Medical Appoints Christina Anne Vice President of Distribution Channel Management 60
  • 6.7 Apr 12, 2018: Microbot Medical's Self-Cleaning Shunt Awarded a Grant by the European Commission 61
  • 6.8 Apr 05, 2018: Dr. Laura Mauri to Join Medtronic as Vice President, Global Clinical Research & Analytics 61
  • 6.9 Mar 23, 2018: 2017 fiscal year: B. Braun increases sales and earnings, with investments of one billion euros 62
  • 6.10 Feb 27, 2018: Integra LifeSciences Reports Fourth Quarter and Full-Year 2017 Financial Results 64
  • 6.11 Feb 21, 2018: LeMaitre Reports Net Income Of $4.3mm In Q4 2017 66
  • 6.12 Feb 20, 2018: Alcyone Lifesciences Completes Spin-Off of Hydrocephalus Business, Anuncia 67
  • 6.13 Feb 13, 2018: Four start-ups chosen for the B. Braun Accelerator Program 67
  • 6.14 Jan 30, 2018: Alex Gu Named Senior Vice President and President of Medtronic's Greater China Region 68
  • 6.15 Jan 08, 2018: Integra LifeSciences Announces Preliminary Fourth Quarter 2017 Financial Result 69

7 Appendix 99

  • 7.1 Methodology 99
  • 7.2 About GlobalData 102
  • 7.3 Contact Us 102
  • 7.4 Disclaimer 102

List of Tables

1.1 List of Tables

  • Table 1: Cerebro Spinal Fluid (CSF) Management - Pipeline Products by Stage of Development 9
  • Table 2: Cerebro Spinal Fluid (CSF) Management - Pipeline Products by Segment 10
  • Table 3: Cerebro Spinal Fluid (CSF) Management - Pipeline Products by Territory 11
  • Table 4: Cerebro Spinal Fluid (CSF) Management - Pipeline Products by Regulatory Path 12
  • Table 5: Cerebro Spinal Fluid (CSF) Management - Pipeline Products by Estimated Approval Date 13
  • Table 6: Cerebro Spinal Fluid (CSF) Management - Ongoing Clinical Trials 14
  • Table 7: Cerebro Spinal Fluid (CSF) Management Companies - Pipeline Products by Stage of Development 15
  • Table 8: Cerebro Spinal Fluid (CSF) Management - Pipeline Products by Stage of Development 17
  • Table 9: Alcyone Lifesciences Inc Pipeline Products & Ongoing Clinical Trials Overview 19
  • Table 10: Alivio Ventricular System - Product Status 19
  • Table 11: Alivio Ventricular System - Product Description 19
  • Table 12: Arkis BioSciences Pipeline Products & Ongoing Clinical Trials Overview 20
  • Table 13: Arkis AutoShunt - Product Status 20
  • Table 14: Arkis AutoShunt - Product Description 20
  • Table 15: Beckersmith Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 21
  • Table 16: FlowSafe - Product Status 21
  • Table 17: FlowSafe - Product Description 21
  • Table 18: Biosan Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 22
  • Table 19: Ventritek105 - Product Status 22
  • Table 20: Ventritek105 - Product Description 22
  • Table 21: CereVasc LLC Pipeline Products & Ongoing Clinical Trials Overview 23
  • Table 22: eShunt - Product Status 23
  • Table 23: eShunt - Product Description 23
  • Table 24: Collagen Matrix Inc Pipeline Products & Ongoing Clinical Trials Overview 24
  • Table 25: DuraMatrix - Product Status 24
  • Table 26: DuraMatrix - Product Description 24
  • Table 27: Georgia Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 25
  • Table 28: Hydrocephalus Shunt - Product Status 25
  • Table 29: Hydrocephalus Shunt - Product Description 25
  • Table 30: H-Cubed Inc. Pipeline Products & Ongoing Clinical Trials Overview 26
  • Table 31: Ambulatory System For Hydrocephalus Shunt - Product Status 26
  • Table 32: Ambulatory System For Hydrocephalus Shunt - Product Description 26
  • Table 33: Integra LifeSciences Holdings Corp Pipeline Products & Ongoing Clinical Trials Overview 27
  • Table 34: Certas Plus Tool Kit - Product Status 27
  • Table 35: Certas Plus Tool Kit - Product Description 28
  • Table 36: Generator - Cerebro Spinal Fluid (CSF) Management - Product Status 28
  • Table 37: Generator - Cerebro Spinal Fluid (CSF) Management - Product Description 28
  • Table 38: Generator CertaPlus - Product Status 28
  • Table 39: Generator CertaPlus - Product Description 29
  • Table 40: Hydrocephalic Shunt - Product Status 29
  • Table 41: Hydrocephalic Shunt - Product Description 29
  • Table 42: Next Generation DuraSeal - Product Status 29
  • Table 43: Next Generation DuraSeal - Product Description 30
  • Table 44: Ventricular Drainage Device - Product Status 30
  • Table 45: Ventricular Drainage Device - Product Description 30
  • Table 46: InVivo Therapeutics Corp Pipeline Products & Ongoing Clinical Trials Overview 31
  • Table 47: Dural Graft - Product Status 31
  • Table 48: Dural Graft - Product Description 31
  • Table 49: Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 32
  • Table 50: CADENCE Balloon Shunt - Product Status 32
  • Table 51: CADENCE Balloon Shunt - Product Description 32
  • Table 52: Kerecis ehf Pipeline Products & Ongoing Clinical Trials Overview 33
  • Table 53: Kerecis Omega3 Dura - Product Status 33
  • Table 54: Kerecis Omega3 Dura - Product Description 33
  • Table 55: Kuros Biosciences AG Pipeline Products & Ongoing Clinical Trials Overview 34
  • Table 56: Neuroseal - Cranial - Product Status 34
  • Table 57: Neuroseal - Cranial - Product Description 34
  • Table 58: Neuroseal - Spinal - Product Status 35
  • Table 59: Neuroseal - Spinal - Product Description 35
  • Table 60: Leucadia Therapeutics Pipeline Products & Ongoing Clinical Trials Overview 36
  • Table 61: Arethusta - Product Status 36
  • Table 62: Arethusta - Product Description 36
  • Table 63: Microbot Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 37
  • Table 64: Self-Cleaning Shunt (SCS) Device - Product Status 37
  • Table 65: Self-Cleaning Shunt (SCS) Device - Product Description 37
  • Table 66: Microbot Medical Ltd - Ongoing Clinical Trials Overview 38
  • Table 67: Self-Cleaning Shunt (SCS) Device - Clinical Investigation of Self-Cleaning Shunt (SCS) Device 39
  • Table 68: Monitor Med Solutions Pipeline Products & Ongoing Clinical Trials Overview 40
  • Table 69: Hydrocephalus Shunt System - Product Status 40
  • Table 70: Hydrocephalus Shunt System - Product Description 40
  • Table 71: Nanonerve Inc. Pipeline Products & Ongoing Clinical Trials Overview 41
  • Table 72: Nanofibrous Dural Substitute - Product Status 41
  • Table 73: Nanofibrous Dural Substitute - Product Description 41
  • Table 74: NeuraMedica, LLC Pipeline Products & Ongoing Clinical Trials Overview 42
  • Table 75: Dural Clip - Product Status 42
  • Table 76: Dural Clip - Product Description 42
  • Table 77: NexGen Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 43
  • Table 78: EViTAR FLOWMETER - Product Status 43
  • Table 79: EViTAR FLOWMETER - Product Description 43
  • Table 80: Nurami Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 44
  • Table 81: Artifascia - Product Status 44
  • Table 82: Artifascia - Product Description 44
  • Table 83: Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 45
  • Table 84: Bovine Pericardium - Dura Substitute - Product Status 45
  • Table 85: Bovine Pericardium - Dura Substitute - Product Description 45
  • Table 86: Programmable Hydrocephalus Stent - Product Status 46
  • Table 87: Programmable Hydrocephalus Stent - Product Description 46
  • Table 88: System Science Inc. Pipeline Products & Ongoing Clinical Trials Overview 47
  • Table 89: Acute Cerebrospinal Fluid Monitor And Control System - Product Status 47
  • Table 90: Acute Cerebrospinal Fluid Monitor And Control System - Product Description 47
  • Table 91: Implantable Cerebrospinal Fluid Monitor And Control System - Product Status 48
  • Table 92: Implantable Cerebrospinal Fluid Monitor And Control System - Product Description 48
  • Table 93: University Hospital Zurich Pipeline Products & Ongoing Clinical Trials Overview 49
  • Table 94: SmartShunt - Product Status 49
  • Table 95: SmartShunt - Product Description 49
  • Table 96: University of Iowa Pipeline Products & Ongoing Clinical Trials Overview 50
  • Table 97: Distal Catheter - Product Status 50
  • Table 98: Distal Catheter - Product Description 50
  • Table 99: University of Rochester Pipeline Products & Ongoing Clinical Trials Overview 51
  • Table 100: Catheterless Shunt System - Product Status 51
  • Table 101: Catheterless Shunt System - Product Description 51
  • Table 102: University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 52
  • Table 103: Shunt Catheter System With Inline Filter - Product Status 52
  • Table 104: Shunt Catheter System With Inline Filter - Product Description 52
  • Table 105: Sonic Window Cranioplasty Implant - Product Status 53
  • Table 106: Sonic Window Cranioplasty Implant - Product Description 53
  • Table 107: University of Wisconsin Madison Pipeline Products & Ongoing Clinical Trials Overview 54
  • Table 108: Gravity And Pressure Controlled Valve System - Product Status 54
  • Table 109: Gravity And Pressure Controlled Valve System - Product Description 54
  • Table 110: Hydrocephalus Stent - Product Status 55
  • Table 111: Hydrocephalus Stent - Product Description 55
  • Table 112: Medical Shunt - Hydrocephalus - Product Status 55
  • Table 113: Medical Shunt - Hydrocephalus - Product Description 55
  • Table 114: Vivonics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 56
  • Table 115: Shunt Flowmeter - Product Status 56
  • Table 116: Shunt Flowmeter - Product Description 56
  • Table 117: Wayne State University Pipeline Products & Ongoing Clinical Trials Overview 57
  • Table 118: Programmable Antisiphon Shunt System - Product Status 57
  • Table 119: Programmable Antisiphon Shunt System - Product Description 57
  • Table 120: Glossary 101

List of Figures

1.2 List of Figures

  • Figure 1: Cerebro Spinal Fluid (CSF) Management - Pipeline Products by Stage of Development 9
  • Figure 2: Cerebro Spinal Fluid (CSF) Management - Pipeline Products by Segment 10
  • Figure 3: Cerebro Spinal Fluid (CSF) Management - Pipeline Products by Territory 11
  • Figure 4: Cerebro Spinal Fluid (CSF) Management - Pipeline Products by Regulatory Path 12
  • Figure 5: Cerebro Spinal Fluid (CSF) Management - Pipeline Products by Estimated Approval Date 13
  • Figure 6: Cerebro Spinal Fluid (CSF) Management - Ongoing Clinical Trials 14
Back to Top
아시아 최대 시장정보 제공
전세계에서 발행되고 있는 모든 시장조사보고서를
다루고 있습니다.
사이트에서 검색되지 않는 보고서도 문의 바랍니다.
 
BCC Research